<![CDATA[LIBRA Study Explores mGluR5 Modulation as Novel Approach for Trigeminal Neuralgia]]>
Details of the phase 2/3 LIBRA trial design highlight the ongoing evaluation of basimglurant, an investigational mGluR5 negative allosteric modulator, for the treatment of trigeminal neuralgia (TN), according to an abstract presented at the 2026 …